As of June 9, 2025, Infinity Pharmaceuticals Inc (INFI) reports a Graham Number of 1.66.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Infinity Pharmaceuticals Inc's Graham Number
Over recent years, Infinity Pharmaceuticals Inc's Graham Number has shown a moderate pattern. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2022-12-31 | 1.66 |
| 2021-12-31 | 1.66 |
| 2020-12-31 | 2.10 |
This gradual decrease highlights how Infinity Pharmaceuticals Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Infinity Pharmaceuticals Inc's Graham Number to Peers
To better understand Infinity Pharmaceuticals Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Infinity Pharmaceuticals Inc (INFI) | 1.66 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Amgen Inc (AMGN) | 43.25 |
| Sierra Oncology Inc (SRRA) | 18.52 |
Compared to its competitors, Infinity Pharmaceuticals Inc's Graham Number is among the lowest compared to peers, which may indicate relative fundamental weakness by Graham's criteria.